LFB USA is a globalized company which develops and provides pharmaceutical bioproducts through its innovative technologies for patients with serious diseases. LFB USA is committed …

LFB USA is a company within the LFB Group, a leading European biopharmaceutical company specialized in innovative biotherapies, marketing its medicinal products around the world.

The proprietary rPRO Technology ™ that drives LFB S.A.'s product development enables production of innovative recombinant therapies that are more cost-effective and scalable …

At LFB USA, we are powering the development and commercialization of highly innovative recombinant therapies to address an ever-growing set of unmet medical needs. To do this …

LFB USA has a key role in developing LFB's pipeline in the US, focusing on research, clinical development and regulatory strategies and filings. For the Factor FVIIa (LR769) program, LFB …

LFB USA is led by a team of business experts and scientists with a successful track record of developing and commercializing important and highly innovative healthcare technologies and …

Framingham biopharmaceutical firm LFB USA has pinned plans to build a new 65,000-square-foot manufacturing and laboratory facility in Marlborough in part on the expectation that its drug, …

For a link to the FDA article: https://www.fda.gov/news-events/press-announcements/fda-approves-additional-treatment-adults-and-adolescents-hemophilia-or-b-and-inhibitors Click …

Within the LFB Group, which is a leader in the field of therapeutic proteins in France, LFB USA enables the production of life-saving medicines within the Group’s key areas of expertise and …

LFB USA is focused on developing and commercializing life-changing and life-saving therapies for patients, particularly in the area of rare diseases. We’re committed to reaching more patients …